Pulse Biosciences Inc.
PLSE | NASDAQ
$53.59
+$1.35 (+2.58%)
Nov 2, 2026, 12:47 PM ET · Market open
Market Data
Market Cap $3.82B
Enterprise Value $3.63B
Beta 1.57
Average Volume 475.13K
Shares Outstanding (Diluted) 69.2M
Shares Change YoY 2.86%
Institutional Ownership 15.70%
Exchange NASDAQ
ISIN US74587B1017
Price Performance
Price Change 1M 11.9%
Price Change 3M 42.0%
Price Change 6M 167.6%
Price Change YTD 290.3%
Price Change 1Y 219.2%
Price Change 3Y 989.2%
Price Change 5Y 135.2%
1M CAGR (ann.) -3.0%
1Y CAGR (ann.) 205.3%
5Y CAGR (ann.) 18.6%
All-Time CAGR 23.9%
Valuation
PE Ratio -44.65
Forward PE N/A
PEG Ratio 4.51
Forward PEG -2.84
PS Ratio 3,144.21
Forward PS 660.40
PB Ratio 37.45
P/FCF Ratio -60.69
P/Adj. FCF Ratio -47.25
P/OCF Ratio -59.36
EV/Sales 3,064.17
EV/EBIT -45.04
EV/EBITDA -45.47
EV/FCF -59.15
Earnings Yield -2.2%
FCF Yield -1.6%
Adj. FCF Yield -2.1%
Financial Health
Net Cash $101.62M
Total Debt $6.77M
Cash & Short-Term Investments $101.62M
Total Assets $115.56M
Current Ratio 9.63
Quick Ratio 9.61
Debt / Equity Ratio 0.07
Debt / EBITDA -0.08
Debt / FCF -0.11
OCF / Debt -9.02
Interest Coverage 0.00
Altman Z-Score 131.72
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin -21.6%
Operating Profit Margin -7007.8%
EBITDA Margin -6717.4%
Net Profit Margin -6755.8%
FCF Margin -5180.4%
Adj. FCF Margin -6654.9%
SBC / Revenue 1474.4%
SBC Impact (per share) -28.5%
Returns
Return on Assets -69.3%
Return on Equity -94.4%
Return on Invested Capital -78.1%
Return on Capital Employed -79.4%
Return on Tangible Assets -71.1%
Historical Growth (CAGR)
Revenue CAGR 3Y 150.0%
Revenue CAGR 5Y -28.4%
Revenue CAGR 10Y 23.4%
EPS CAGR 3Y -18.8%
EPS CAGR 5Y 14.8%
EPS CAGR 10Y 6.3%
FCF CAGR 3Y -27.4%
FCF CAGR 5Y -5.0%
FCF CAGR 10Y -11.0%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 2
EPS Growth Next 3Y 11.7%
Revenue Growth Next 3Y 270.2%
Earnings Date Nov 5, 2026
EPS Estimate (next Q) -$0.31
EPS Growth Est (next Q) 6.7%
Revenue Est (next Q) $520.83K
Revenue Growth Est (next Q) 505.6%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $60.20
Price Target Upside 15.2%
Cash Flow
Operating Cash Flow $-61.1M
Free Cash Flow $-61.39M
Adj. Free Cash Flow $-78.86M
FCF Per Share -$0.89
OCF Per Share -$0.88
OCF/S Ratio -5155.9%
Income Statement
Revenue $1.19M
Gross Profit $-256K
Operating Income $-83.04M
EBITDA $-79.86M
Net Income $-80.06M
EPS (Diluted) -$1.17
Revenue / Employee $10.22K
Profit / Employee $-690.14K
Employees 116
Add to Watchlist
Select watchlists to add or remove PLSE